What You Need To Know About Byetta and Januvia Lawsuits

Byetta and Januvia are drugs commonly used in the United States to treat Type 2 diabetes. While Byetta and Januvia have been approved for use by FDA since 2005 and 2006 respectively, numerous lawsuits have been filed claiming that these diabetes medications led to serious, sometimes life-threatening complications.

The lawyers at injurylawsuithelp.com have years of experience representing individuals in numerous personal injury cases including lawsuits for those you have experienced adverse side effects after using a particular defective drug. We have been successful in countless of lawsuits filed against international companies like Merck who decided to put profits before the safety of patients.

It is believed that Merck currently manufactures of Januvia made billions of dollars from the sale of this blockbuster drug. In fact, Januvia outperformed every other Merk product in terms of sales. While Byetta which is made by Amylin, Eli Lilly and Bristol-Myers Squibb, have earned millions in sales of the drug over the years. Our experienced personal injury lawyers assist patients who have been using these diabetes medications for years and experienced adverse side effects so that they could get compensated.

Byetta and Januvia– how do they work?

People who cannot produce enough insulin suffer Type 2 diabetes. Insulin role in a human body is transport sugar from blood into cells. Sugar is essential for cells’ growth and survival. On the other hand, when blood sugar is high, patients risk liver and kidney damage, blindness, heart disease and and other serious conditions.

Both Byetta and Januvia assist control the effects of an enzyme (called DPP-IV) that interferes with the body’s release of insulin. They belong to a class of drugs called incretin mimetics. Byetta evades DPP-IV by providing insulin-stimulating proteins that are immune to the enzyme’s effects while Januvia prevents the enzyme from working. In 2005, Byetta was approved by the FDA approved for patients whose blood sugar could not be properly regulated using existing medications. The FDA approved Januvia as the first so-called DPP-IV inhibitor in 2006. A DPP-IV inhibitor is a new type of diabetes medication that, in conjunction with diet and exercise, could assist individuals with Type 2 diabetes regulate their blood sugar levels.

Byetta and Januvia Complications

Both Byetta and Januvia have various side effects, some of which are quite insignificant. However, both medications have pancreatic cancer links, which normally forms the basis of Byetta and Januvia lawsuits.

Byetta’s Complications include:

  • Severe allergic reactions
  • Pancreatic cancer
  • Thyroid cancer
  • Acute pancreatitis
  • Kidney damage or failure

Januvia’s serious side effects include:

  • Pancreatitis (inflammation of the pancreas) that can be fatal
  • Kidney failure
  • Thyroid cancer
  • Pancreatic cancer

Talk to a Reputable Personal Injury Lawyer

Here at injury Lawsuit Help, our main aim has always been in helping injured individuals get their day in court. We believe that no one should have to risk life-threatening complications such as pancreatitis, thyroid cancer or pancreatic cancer simply because they use a certain diabetes medication. But if a person with diabetes does experience complications then they deserve full compensation.


It's only fair to share...Share on FacebookShare on Google+Tweet about this on TwitterPin on PinterestShare on LinkedInDigg thisShare on TumblrShare on RedditEmail this to someone

Leave a Reply

Your email address will not be published. Required fields are marked *